Recent News

• 05.14.2026 - MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
• 05.13.2026 - MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
• 05.11.2026 - MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
• 04.08.2026 - FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
• 03.09.2026 - MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Recent Filings

• 05.14.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.14.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.13.2026 - EX-99.1 EX-99.1
• 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2026 - 8-K Current report
• 05.12.2026 - EX-99.1 EX-99.1
• 05.12.2026 - 8-K Current report
• 05.04.2026 - EX-99.1 EX-99.1
• 05.04.2026 - 8-K Current report
• 04.22.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material